Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Anna ZabalzaGeorgina ArrambideSusana Otero-RomeroAgustín PappollaPaula TaglianiSamuel López-MazaSimón Cárdenas-RobledoJuliana EsperalbaCandela Fernández-NavalMónica Martinez-GalloMireia CastilloMercè BonastreMireia Resina-SallesJordina BertranMarta Rodriguez-BarrancoPere Carbonell-MirabentMarina GonzalezMiguel MerchanAna Quiroga-VarelaAlbert MiguelaImma GómezGary Álvarez BravoRené RoblesDúnia Perez Del CampoXavier QueraltMaria José SolerIrene AgrazFernando Martinez-ValleBreogan Rodriguez AcevedoLuciana MidagliaÁngela Vidal-JordanaÁlvaro Cobo-CalvoCarmen TurIngrid GalanJoaquín CastilloJordi RíoCarmen EspejoManuel ComabellaCarlos NosJaume Sastre-GarrigaLluís Ramió-TorrentàMar TintoreXavier MontalbanPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Anti-CD20s and S1PRM modify the immunological responses to SARS-CoV-2 vaccines.